Anest. intenziv. Med. 2016;27(5):290-293

KOMENTÁŘ II. Aprotinin - další pohled na rizika, aneb dočkáme se šťastného konce příběhu?Anaesthesiology - Special Article

M. Horáček
Klinika anesteziologie, resuscitace a intenzivní medicíny 2. lékařské fakulty Univerzity Karlovy a Fakultní nemocnice v Motole, Praha

Received: August 1, 2016; Accepted: August 2, 2016; Published: October 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Horáček M. KOMENTÁŘ II. Aprotinin - další pohled na rizika, aneb dočkáme se šťastného konce příběhu? Anest. intenziv. Med. 2016;27(5):290-293.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Frey, E. K. On the treatment of pancreatitis. Therapiewoche, 1953, 13-14, p. 323.
    2. Royston, D., Taylor, K. M., Bidstrup, B. P., Sapsford, R. N. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet, 1987, 330, p. 1289-1291. Go to original source... Go to PubMed...
    3. Van Aelbrouck, C., Englberger, L., Faraoni, D. Review of the fibrinolytic system: comparison of different antifibrinolytics used during cardiopulmonary bypass. Recent Pat. Cardiovasc. Drug Discov., 2012, 7, 3, p. 175-179. Go to original source... Go to PubMed...
    4. Mangano, D. T., Tudor, I. C., Dietzel, C. The risk associated with aprotinin in cardiac surgery. N. Engl. J. Med., 2006, 354, p. 353-365. Go to original source... Go to PubMed...
    5. Mangano, D. T., Miao, Y., Vuylsteke, A. et al. Mortality associated with aprotinin during 5 years following coronary artery bypass surgery. J. Am. Med. Assoc., 2007, 297, p. 471-479. Go to original source... Go to PubMed...
    6. Fergusson, D. A., Hébert, P. C., Mazer, C. D., Fremes, S., MacAdams, C., Murkin, J. M., Teoh, K., Duke, P. C., Arellano, R., Blajchman, M. A., Bussières, J. S., Côté, D., Karski, J., Martineau, R., Robblee, J. A., Rodger, M., Wells, G., Clinch, J., Pretorius, R., BART Investigators. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N. Engl. J. Med., 2008, 358, 22, p. 2319-2331. Go to original source... Go to PubMed...
    7. Hébert, P. C., Fergusson, D. A., Hutton, B., Mazer, C. D., Fremes, S., Blajchman, M., MacAdams, C., Wells, G., Robblee, J., Bussières, J., Teoh, K., BART Investigators. Regulatory decisions pertaining to aprotinin may be putting patients at risk. CMAJ., 2014, 186, 18, p. 1379-1386. Go to original source... Go to PubMed...
    8. European Medicines Agency recommends suspension of marketing authorisation of aprotinin-containing medicines for systemic use. http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2009/11/WC500015517.pdf (poslední přístup 31.7.2016).
    9. European Medicines Agency recommends lifting suspen-sion of aprotinin. http://www.ema.europa.eu/ema/pages/news_and_events/news/2012/02/news_detail_001447.jsp (poslední přístup 31.7.2016).
    10. Aprotinin: is it time to reconsider? The European Society of Anaesthesiology task force reports on the place of aprotinin in clinical anaesthesia. European Journal of Anaesthesiol., 2015, 32, p. 591-595. Go to original source... Go to PubMed...
    11. DeSantis, S. M., Toole, J. M., Kratz, J. M., Uber, W. E., Wheat, M. J., Stroud, M. R., Ikonomidis, J. S., Spinale, F. G. Early postoperative outcomes and blood product utilization in adult cardiac surgery: the post-aprotinin era. Circulation, 2011, 124, 11 Suppl., p. S62-S69. Go to original source... Go to PubMed...
    12. Walkden, G. J., Verheyden, V., Goudie, R., Murphy, G. J. Increased perioperative mortality following aprotinin withdrawal: a real-world analysis of blood management strategies in adult cardiac surgery. Intensive Care Med., 2013, 39, 10, p. 1808-1817. Go to original source... Go to PubMed...
    13. Karkouti, K., Wijeysundera, D. N., Yau, T. M., McCluskey, S. A., Tait, G., Beattie, W. S. The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery. Anesth. Analg., 2010, 110, 1, p. 21-29. Go to original source... Go to PubMed...
    14. Meybohm, P., Herrmann, E., Nierhoff, J., Zacharowski, K. Aprotinin may increase mortality in low and intermediate risk but not in high risk cardiac surgical patients compared to tranexamic acid and ε-aminocaproic acid - a meta-analysis of randomised and observational trials of over 30.000 patients. PLoS One, 2013, 8, 3, p. e58009. Go to original source... Go to PubMed...
    15. Ranucci, M., Bozzetti, G., Ditta, A., Cotza, M., Carboni, G., Ballotta, A. Surgical reexploration after cardiac operations: why a worse outcome? Ann. Thorac. Surg., 2008, 86, 5, p. 1557-1562. Go to original source... Go to PubMed...
    16. Beattie, W. S., Karkouti, K. The post-BART anti-fibrinolytic dilemma? J. Cardiothorac. Vasc. Anesth., 2011, 25, 1, p. 3-5. Go to original source... Go to PubMed...
    17. Cvachovec, K., Horáček, M., Vislocký, I. A retrospective survey of fibrinolysis as an indicator of poor outcome after cardiopulmonary bypass and a possible early sign of systemic inflammation syndrome. Eur. J. Anaesthesiol., 2000, 17, 3, p. 173-176. Go to original source...
    18. Whitten, C. W., Allison, P., Latson, T., Ivy, R., Burkhardt, D., O'Flaherty, D. Does fibrinolytic activity differ with different cardiac surgical procedures? Anesthesiology, 1991, 75, Suppl., p. A521. Go to original source... Go to PubMed...
    19. Lin, Z., Xiaoyi, Z. Tranexamic acid-associated seizures: A meta-analysis. Seizure, 2016, 36, p. 70-73. Go to original source... Go to PubMed...
    20. Lecker, I., Wang, D. S., Whissell, P. D., Avramescu, S., Mazer, C. D., Orser, B. A. Tranexamic acid-associated seizures: Causes and treatment. Ann. Neurol., 2016, 79, 1, p. 18-26. Go to original source... Go to PubMed...
    21. Kozek-Langenecker, S. A, Afshari, A., Albaladejo, P., Santullano, C. A., De Robertis, E., Filipescu, D. C., Fries, D., Görlinger, K., Haas, T., Imberger, G., Jacob, M., Lancé, M., Llau, J., Mallett, S., Meier, J., Rahe-Meyer, N., Samama, C. M., Smith, A., Solomon, C., Van der Linden, P., Wikkelsø, A. J., Wouters, P., Wyffels, P. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur. J. Anaesthesiol., 2013, 30, 6, p. 270-382. Go to original source... Go to PubMed...
    22. Chakrabarti, R., Hocking, E. D., Fearnley, G. R. Reaction pattern to three stresses - electroplexy, surgery, and myocardial infarction - of fibrinolysis and plasma fibrinogen. J. Clin. Pathol., 1969, 22, 6, p. 659-662. Go to original source... Go to PubMed...
    23. Moore, H. B., Moore, E. E., Gonzalez, E., Chapman, M. P., Chin, T. L., Silliman, C. C., Banerjee, A., Sauaia, A. Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy. J. Trauma Acute Care Surg., 2014, 77, 6, p. 811-817. Go to original source... Go to PubMed...

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.